JnJ Collaborates with The MTV Staying Alive Foundation to Launch health campaigns for Indian Youth Medical Dialogues Bureau19 Jan 2020 10:00 AM ISTMumbai: Johnson & Johnson Services Inc. has announced its collaboration with the internationally acclaimed social change organization The MTV...
Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent Medical Dialogues Bureau1 Nov 2019 3:29 PM ISTScale-up of affordable Rifapentine stands to benefit over a million people in India alone, where more people suffer from TB than anywhere else in the...
JnJ enters series of new collaborations with Government, NGOs for ending TB in India by 2025 Farhat Nasim31 Oct 2019 12:39 PM ISTHyderabad: Johnson & Johnson(JnJ) recently announced the expansion of its tuberculosis (TB) program in India in advance of the 50th Union World...
Mylan moves application with DCGI to launch new TB drug Pretomanid in India Medical Dialogues Bureau16 Oct 2019 4:10 PM IST"We have submitted the new drug application to the office of DCGI. We are in an advanced stage of discussion and are working with the office of...
JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030 Medical Dialogues Bureau7 Oct 2019 9:30 AM ISTNEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver Farhat Nasim28 May 2019 4:21 PM ISTNew Delhi: Apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has been recommended by the Techincal Committee to granted...
Mylan, TB Alliance to commercialize Pretomanid to treat TB Farhat Nasim23 April 2019 10:00 AM ISTTB Alliance began preclinical development of pretomanid in 2002, and it has since studied pretomanid in 20 clinical trials alone or in combination...
Cutting TB drugs prices in India: Johnson and Johnson, Mylan propose ways Ruby Khatun Khatun18 March 2018 3:51 PM ISTNew Delhi: To provide their Multidrug-Resistant (MDR) TB drugs at cheaper rates to TB patients in India so that patients could easily access to them...
Magma HDI forays into health insurance with OneHealth policy Ruby Khatun Khatun2 Dec 2017 9:45 AM ISTNew Delhi: Non-banking finance company Magma Fincorp has forayed into health insurance business through its joint-venture Magma HDI General Insurance...
Cipla gets WHO approval to sell TB preventing drug in HIV patients Ruby Khatun Khatun1 Dec 2017 2:40 PM ISTNew Delhi: Drug major Cipla said it has received approval from the World Health Organisation (WHO) for Q-TIB, a combination drug indicated to help...
NPPA slashes price of 39 drugs: check out details Ruby Khatun Khatun21 Sept 2017 10:34 AM ISTNew Delhi: Drug price regulator NPPA on Wednesday said it has fixed the ceiling price for 39 more drug formulations, including those used for the...
